vs
Side-by-side financial comparison of Bowhead Specialty Holdings Inc. (BOW) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.
USANA HEALTH SCIENCES INC is the larger business by last-quarter revenue ($250.2M vs $155.7M, roughly 1.6× Bowhead Specialty Holdings Inc.). Bowhead Specialty Holdings Inc. runs the higher net margin — 10.3% vs 3.0%, a 7.3% gap on every dollar of revenue. On growth, Bowhead Specialty Holdings Inc. posted the faster year-over-year revenue change (26.9% vs -3.0%).
Bowhead Specialty Holdings Inc. is a specialty insurance holding company that offers a diversified portfolio of property and casualty insurance products, focusing on underserved niche market segments primarily across North America. It provides tailored risk management solutions and specialized coverage options for both commercial and individual clients.
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
BOW vs USNA — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2027
| Metric | | |
|---|---|---|
| Revenue | $155.7M | $250.2M |
| Net Profit | $16.0M | $7.5M |
| Gross Margin | — | 76.2% |
| Operating Margin | — | 5.5% |
| Net Margin | 10.3% | 3.0% |
| Revenue YoY | 26.9% | -3.0% |
| Net Profit YoY | — | -20.0% |
| EPS (diluted) | $0.48 | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $155.7M | $250.2M | ||
| Q4 25 | $151.7M | $226.2M | ||
| Q3 25 | $143.9M | $213.7M | ||
| Q2 25 | $133.3M | $235.8M | ||
| Q1 25 | $122.7M | $249.5M | ||
| Q4 24 | — | $213.6M | ||
| Q3 24 | $116.8M | $200.2M | ||
| Q2 24 | $98.9M | — |
| Q1 26 | $16.0M | $7.5M | ||
| Q4 25 | $14.8M | $180.0K | ||
| Q3 25 | $15.2M | $-6.5M | ||
| Q2 25 | $12.3M | $9.7M | ||
| Q1 25 | $11.4M | $9.4M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | $12.1M | $10.6M | ||
| Q2 24 | $5.5M | — |
| Q1 26 | — | 76.2% | ||
| Q4 25 | — | 78.2% | ||
| Q3 25 | — | 77.2% | ||
| Q2 25 | — | 78.7% | ||
| Q1 25 | — | 79.0% | ||
| Q4 24 | — | 82.0% | ||
| Q3 24 | — | 80.4% | ||
| Q2 24 | — | — |
| Q1 26 | — | 5.5% | ||
| Q4 25 | 11.7% | 1.7% | ||
| Q3 25 | 13.3% | 0.6% | ||
| Q2 25 | 11.9% | 7.1% | ||
| Q1 25 | 11.8% | 6.3% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | 13.5% | 7.8% | ||
| Q2 24 | 7.5% | — |
| Q1 26 | 10.3% | 3.0% | ||
| Q4 25 | 9.8% | 0.1% | ||
| Q3 25 | 10.5% | -3.1% | ||
| Q2 25 | 9.3% | 4.1% | ||
| Q1 25 | 9.3% | 3.8% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | 10.4% | 5.3% | ||
| Q2 24 | 5.6% | — |
| Q1 26 | $0.48 | $0.41 | ||
| Q4 25 | $0.44 | $-0.10 | ||
| Q3 25 | $0.45 | $-0.36 | ||
| Q2 25 | $0.36 | $0.52 | ||
| Q1 25 | $0.34 | $0.49 | ||
| Q4 24 | — | $0.23 | ||
| Q3 24 | $0.36 | $0.56 | ||
| Q2 24 | $0.20 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $97.2M | $162.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $457.9M | — |
| Total Assets | $2.5B | $739.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $97.2M | $162.8M | ||
| Q4 25 | $193.5M | $158.4M | ||
| Q3 25 | $197.9M | $145.3M | ||
| Q2 25 | $114.8M | $151.3M | ||
| Q1 25 | $88.0M | $179.6M | ||
| Q4 24 | — | $181.8M | ||
| Q3 24 | $132.9M | $364.9M | ||
| Q2 24 | $180.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | $146.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $457.9M | — | ||
| Q4 25 | $448.3M | — | ||
| Q3 25 | $430.2M | $528.1M | ||
| Q2 25 | $407.2M | $531.1M | ||
| Q1 25 | $391.0M | $529.8M | ||
| Q4 24 | — | $532.1M | ||
| Q3 24 | $364.7M | $533.1M | ||
| Q2 24 | $339.9M | — |
| Q1 26 | $2.5B | $739.0M | ||
| Q4 25 | $2.4B | $742.9M | ||
| Q3 25 | $2.1B | $726.6M | ||
| Q2 25 | $1.9B | $734.5M | ||
| Q1 25 | $1.8B | $746.6M | ||
| Q4 24 | — | $748.2M | ||
| Q3 24 | $1.5B | $671.3M | ||
| Q2 24 | $1.4B | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.33× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
